5PSQ-112 Evaluation of the use of infliximab in immune checkpoint inhibitor-induced adverse reactions
DOI:
10.1136/ejhpharm-2025-eahp.407
Publication Date:
2025-03-12T09:05:57Z
AUTHORS (8)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....